Insmed reported $807.82M in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acelrx Pharmaceuticals ACRX:US USD 7.89M 2M
Alimera Sciences ALIM:US USD 44.14M 337K
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 610.73M 411.31M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Novartis NVS:US USD 28.44B 2.59B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M